封面
市场调查报告书
商品编码
1635543

全球硬膜替代物市场 - 市场规模(依细分市场)、占有率、监管、偿付、治疗、预测(~2036年)

Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告对全球硬膜替代物市场进行了深入分析,提供了依地区划分的市场规模、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要组成如下:

已上市的硬膜替代物和不断变化的竞争格局

  • 主要产业趋势分析
  • 硬膜替代物市场各细分市场的年收入及市场预测(2015-2036年)
  • 单位数量、平均销售价格和市场价值的市场层面资料

全球、区域和国家层面的市场洞察

  • 依地区和全球趋势细分的定性市场讯息,并提供每个国家/地区的市场洞察
  • 硬膜替代物市场的SWOT 分析
  • 硬膜替代物市场竞争动态的考察与趋势

掌握包括医疗保健系统概况在内的真实全局,加深对市场的了解。此外,市场进入部分提供有关偿付政策和监管环境的资讯,可以更深入地了解市场动态。

  • 各国医疗保健体系概述
  • 各国的偿付政策
  • 各国医疗科技监理状况

目标公司

  • Integra LifeSciences Corp
  • B. Braun Melsungen AG
  • Medtronic Plc
  • DePuy Synthes Inc
  • Regenity Biosciences
  • Baxter International Inc
  • 其他
简介目录
Product Code: GDME560MM

Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

These are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. Biological dura substitutes and synthetic dura substitutes are tracked under this segment.

Dural tears are a risk in craniotomy and spinal fusion surgeries. Inadequate repair can lead to cerebrospinal fluid leakage, infection, and neurological deficits. Small tears are closed watertight, while larger ones require dura substitutes. Dura substitutes are more commonly used in craniotomy procedures than in spinal interventions.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Dura Substitutes and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Dura Substitutes market revenue by segment and market outlooks from 2015-2036.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Dura Substitutes market.
  • Competitive dynamics insights and trends provided for Dura Substitutes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Dura Substitutes marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Dura Substitutes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Dura Substitutes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Dura Substitutes market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.